These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Reduction of gastric hypersecretion in Zollinger-Ellison syndrome with omeprazole. Oberg K; Lindström H Lancet; 1983 Jan; 1(8314-5):66-7. PubMed ID: 6129395 [No Abstract] [Full Text] [Related]
47. Treatment of patients with Zollinger-Ellison syndrome. Mignon M; Pospai D; Forestier S; Vatier J; Vallot T Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592 [TBL] [Abstract][Full Text] [Related]
48. Omeprazole: a comprehensive review. Massoomi F; Savage J; Destache CJ Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967 [TBL] [Abstract][Full Text] [Related]
49. Management of patients with the Zollinger-Ellison syndrome. Mocek FW; Richardson R; Williams R; Richardson JD J Ky Med Assoc; 1993 Sep; 91(9):403-7. PubMed ID: 7901311 [TBL] [Abstract][Full Text] [Related]
50. Omeprazole. Friedman G Am J Gastroenterol; 1987 Mar; 82(3):188-91. PubMed ID: 3548325 [No Abstract] [Full Text] [Related]
51. [Indications and use of omeprazole in esophago-gastro-duodenal diseases]. Martín de Argila C; Boixeda de Miquel D; Moreira Vicente V; García Plaza A Rev Clin Esp; 1999 Nov; 199(11):729-39. PubMed ID: 10638238 [No Abstract] [Full Text] [Related]
52. [Omeprazole treatment in the Zollinger-Ellison syndrome]. Bardram L; Stage JG; Stadil F Ugeskr Laeger; 1985 Mar; 147(10):867-9. PubMed ID: 3984061 [No Abstract] [Full Text] [Related]